A new research perspective titled "The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy" has been published in Oncotarget. CD200 is an immunoregulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results